Multiple Sclerosis with Emotionality Clinical Trial
Multiple Sclerosis (MS) Patients with Emotionality
If you or someone you know experience episodes of uncontrollable laughing and/or crying, you may be eligible for a clinical study now underway to find a treatment for this condition.
A clinical research trial is actively enrolling patients to evaluate the efficacy and safety of a targeted treatment known as AVP-923. The study is recruiting patients with MS or other neurological disorders who also have pseudobulbar affect, a condition characterized by episodes of uncontrollable laughing and/or crying. An estimated 10 percent of MS patients suffer from pseudobulbar affect.
To determine if you or someone you know is eligible for one of the studies, please call Coordinated Clinical Research at 858-455-5463.
Participants Must:
- Be between 18 and 80 years of age
- Meet all trial criteria
You can sign up for this trial here!